Company Investors Find a Physician News Careers Germany Search

Sales: 650.962.8100 Support: 800.388.4747

Age-Related Macular Degeneration (AMD)

A preliminary study¹ and physician experience^2-3 suggest a possible role for MicroPulse^® laser therapy as an adjunctive treatment in drug-tolerant eyes with neovascular AMD.

An additional study suggests a role for MicroPulse as a retinal protective therapy in high-risk AMD and other chronic progressive retinal diseases.⁴

60-year-old male with neovascular AMD

(A) July 2015 | post multiple anti-VEGF injections over 2 years and prior to MicroPulse | CRT 356 µm
VA 20/40

(B) Sept. 2015 | 2 months post MicroPulse | CRT 195 µm
VA 20/40

*Images compliments of Ziad Bashshur, MD. Read More

Schedule a hands-on demo

Schedule a no-obligation demo to see for yourself how MicroPulse Technology and Iridex’s Family of Products can take YOUR practice to the next level.

Schedule a demo

Solutions
Clinical
Case Reports

IQ 577^® laser

PRODUCT HIGHLIGHTS

Repeatable retinal therapeutic capabilities: macular and foveal
Success with refractory and sub-clinical edema

TxCell^® Scanning Laser Delivery System

High Versatility for Higher Volume

Multi-spot pattern scanning for efficient retinal photocoagulation
Standard coagulation with optimized wavelengths: IQ 532^® or true-yellow IQ 577^® lasers
Confluent laser patterns for tissue-sparing⁵ MicroPulse^® protocols*
Compatible with Iridex, Haag-Streit and Zeiss style slit lamps

Download Brochure

Laser resensitization of medically unresponsive neovascular age-related macular degeneration. Efficacy and Implications.

Luttrull JK, Chang DB, Margolis BWL et al.

pdf View Abstract

Functionally guided retinal protective therapy for dry age-related macular and inherited retinal degenerations: A Pilot Study.

Luttrull JK, Margolis BW.

pdf View Abstract

		Laser therapy for retinal pathologies Brian Horsman, MD, FRCS Download Now
		MicroPulse^® Laser Therapy Resolves Persistent Fluid When Added to Anti-VEGF in AMD Patient Bashshur Z. Download Now
		Rethinking the Regimen for Retinal Disease Management. MicroPulse laser may extend anti-VEGF treatment intervals in several retinal diseases Mahootchi A. Download Now
		Prophylactic Treatment of Age-Related Maculopathy with 577-nm Subthreshold MicroPulse Laser Rykov S, Pasechnikova N, Suk S, Saksonov S. Download Now

1. Luttrull JK, Chang DB, Margolis BW, Dorin G, Luttrull DK. Laser resensitization of medically unresponsive neovascular age-related macular degeneration: Efficacy and implications. Retina, 2015;35:(6)1184-94.
2. Bashshur Z. MicroPulse Laser therapy resolves persistent fluid when added to anti-VEGF in AMD patient. Retinal Physician 2016:July: S1-S2.
3. Mahootchi A. Rethinking the regimen for retinal disease management. Retina Today 2014; November-December:48-50.
4. Luttrull K, Margolis BW. Functionally guided retinal protective therapy for dry age-related macular and inherited retinal degenerations: A pilot study. Invest Ophthal Vis Sci 2016 57(1): 265-275.
5. Bhagat N, Zarbin M, Mansour S, Chong V, and Cardillo JA. Fovea-friendly MicroPulse Laser. Supplement to Retina Today, May/June 2012

Age-Related Macular Degeneration (AMD)

A preliminary study¹ and physician experience^2-3 suggest a possible role for MicroPulse^® laser therapy as an adjunctive treatment in drug-tolerant eyes with neovascular AMD.

An additional study suggests a role for MicroPulse as a retinal protective therapy in high-risk AMD and other chronic progressive retinal diseases.⁴

Schedule a hands-on demo

IQ 577^® laser

PRODUCT HIGHLIGHTS

TxCell^® Scanning Laser Delivery System

Laser resensitization of medically unresponsive neovascular age-related macular degeneration. Efficacy and Implications.

Functionally guided retinal protective therapy for dry age-related macular and inherited retinal degenerations: A Pilot Study.

Laser therapy for retinal pathologies

MicroPulse^® Laser Therapy Resolves Persistent Fluid When Added to Anti-VEGF in AMD Patient

Rethinking the Regimen for Retinal Disease Management. MicroPulse laser may extend anti-VEGF treatment intervals in several retinal diseases

Prophylactic Treatment of Age-Related Maculopathy with 577-nm Subthreshold MicroPulse Laser

Products

Resources

About Iridex

Company

Age-Related Macular Degeneration (AMD)

A preliminary study1 and physician experience2-3 suggest a possible role for MicroPulse® laser therapy as an adjunctive treatment in drug-tolerant eyes with neovascular AMD.

An additional study suggests a role for MicroPulse as a retinal protective therapy in high-risk AMD and other chronic progressive retinal diseases.4

Schedule a hands-on demo

Schedule a demo today!

IQ 577® laser

PRODUCT HIGHLIGHTS

TxCell® Scanning Laser Delivery System

Laser resensitization of medically unresponsive neovascular age-related macular degeneration. Efficacy and Implications.

Functionally guided retinal protective therapy for dry age-related macular and inherited retinal degenerations: A Pilot Study.

Laser therapy for retinal pathologies

MicroPulse® Laser Therapy Resolves Persistent Fluid When Added to Anti-VEGF in AMD Patient

Rethinking the Regimen for Retinal Disease Management. MicroPulse laser may extend anti-VEGF treatment intervals in several retinal diseases

Prophylactic Treatment of Age-Related Maculopathy with 577-nm Subthreshold MicroPulse Laser

Products

Resources

About Iridex

Company

A preliminary study¹ and physician experience^2-3 suggest a possible role for MicroPulse^® laser therapy as an adjunctive treatment in drug-tolerant eyes with neovascular AMD.

An additional study suggests a role for MicroPulse as a retinal protective therapy in high-risk AMD and other chronic progressive retinal diseases.⁴

IQ 577^® laser

TxCell^® Scanning Laser Delivery System

MicroPulse^® Laser Therapy Resolves Persistent Fluid When Added to Anti-VEGF in AMD Patient